Statistics

Total Visits

Views
DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE "WARNING" RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?60

Select a period of time:

Number of views in the range

Views
DO CHRONIC MYELOID LEUKEMIA PATIENTS WITH LATE "WARNING" RESPONSES BENEFIT FROM SWITCHING THERAPY TO A SECOND GENERATION TYROSINE KINASE INHIBITOR?42

Views

Views
February 20252
March 202518
April 20255
May 20253
June 20251
July 202510
August 20253
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States16
Singapore16
Brazil4
Argentina1
Spain1
United Kingdom1
Hong Kong1
 

Top cities views

Views
Cachoeira do Sul1
Columbus1
Council Bluffs1
Eastleigh1
Florianópolis1
Hong Kong1
San Angelo1
Smithfield1
São Paulo1
Taquarituba1